Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CorMedix Inc. Director's Dealing 2011

Jan 19, 2011

32333_dirs_2011-01-19_3c33b765-5baa-4bdd-be11-cb4425c380d3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2011-01-14

Reporting Person: Cohen Richard (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-01-14 Stock option (right to buy) $2.10 A 30000 Acquired 2021-01-14 Common Stock, $0.001 par value per share (30000) Direct

Footnotes

F1: These options vest on January 14, 2012.